We are testing a new drug for patients with advanced solid tumors that have specific genetic mutations. The study aims to assess the safety and how the body handles this treatment in those who have not responded to other therapies.
Health conditions and diseases that the clinical trial is designed to study and treat.
Malignant mast cell tumors are a type of cancer that arises from mast cells, which are part of the immune system. These tumors can occur in various organs and may lead to symptoms such as skin rashes, abdominal pain, and anaphylaxis.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.